Reports

The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

MEDICAL FRONTIERS - International Continence Society / International Urogynecological Association (ICS/IUGA)

Antimuscarinic Efficacy and Predictability in Overactive Bladder

Toronto, Ontario / August 23-27, 2010

Toronto - Symptoms of overactive bladder (OAB), which include urgency with or without incontinence, increased daytime frequency and nocturia, are very distressing. They affect quality of life and the ability to engage in physical...

MEDICAL FRONTIERS - 23rd International Congress of the Transplantation Society

Perspective on Once-daily Immunosuppressive Therapy

Vancouver, British Columbia / August 15-19, 2010

Vancouver - Following organ transplantation, monitoring for optimal drug blood levels of immunosuppressive therapy is important, as lower levels may reduce efficacy while peaks in drug levels may carry an increased risk of toxicity. While a...

RESOURCE LINE - Pediatric Nutrition

Simple Strategies and Solutions for Common Nutritional Deficiencies in Infants and Children

Summer 2010

Optimizing nutrition for very low birth-weight (VLBW) preterm infants on through to children with a variety of feeding difficulties was the focus of a co-developed presentation here at the Canadian Paediatric Society’s (CPS) annual...

NEW FRONTIERS - XVIII International AIDS Conference (IAS)

Seeking Optimal First-line NRTI Backbones: Weighing the Evidence

Vienna, Austria / July 18-23, 2010

The most commonly used first-line nucleoside reverse transcriptase inhibitor (NRTI) combinations are abacavir/lamivudine (ABC/3TC) and tenofovir/emcitrabine (TDF/FTC). In most guidelines, both are considered appropriate for what is referred...

PRIORITY PRESS - XVIII International AIDS Conference (IAS)

Relative Strengths and Clinical Use of CCR5 Entry Inhibitors

Vienna, Austria / July 18-23, 2010

In patients with a failing immune system due to HIV infection, combination antiretroviral therapy (ART) must be maintained more or less continuously to control disease. The combination of two nucleoside reverse transcriptase inhibitors...

PRIORITY PRESS - Alzheimer’s Association International Conference on Alzheimer’s Disease (ICAD)

New Diagnostic Criteria and Evaluations of Alzheimer’s Disease Treatments

Honolulu, Hawaii / July 10-15, 2010

Honolulu - Recent research discussed here during the scientific sessions has highlighted the increasing prevalence and high cost of Alzheimer’s disease (AD). On the other hand, studies are also showing that early interventions with case...

PRIORITY PRESS - 26th International Papillomavirus Conference

Reducing the Burden of HPV-related Disease in Men and Women

Montreal, Quebec / July 3-8, 2010

According to Dr. Suzanne Garland, Director, Microbiological Research, Royal Women’s Hospital, Melbourne, Australia, genital warts (GWs) are the most common condition seen in sexual health services in the country. Multiple visits are...

PRIORITY PRESS - 26th International Papillomavirus Conference and Clinical and Public Health Workshops

Enhanced Treatment Strategies for External Genital Warts

Montreal, Quebec / July 3-8, 2010

It is estimated that approximately 75% to 80% of sexually active men and women have been exposed to genital human papillomavirus (HPV). Types 6 and 11 are the cause of most cases of genital warts (GW) worldwide (J Am Osteopath Assoc...

FRONTLINE - Hematology/Oncology

Evolving Standards of Therapy in Multiple Myeloma

June 2010

Reviewed and edited by: Kevin W

PAGE 46 OF 124   ... 41 42 43 44 45 46 47 48 49 50 ...